AstraZeneca PLC's FluMist Quadrivalent nasal spray flu vaccine will be widely available again as the company has shipped the first of 2.7 million doses for the 2018-2019 flu season.
The company announced the first shipments of FluMist in a Sept. 25 release. AstraZeneca was able to increase the supply...






